Abstract
The clinical applications and investigations of positron emission tomography (PET) have recently been increasing. The majority of the clinical PET studies and the use of 18F-fluoro-2-deoxyglucose (FDG) are related to oncology, but the uptake of this radiopharmaceutical is not specific to malignant tissue. There are several physiologic uptakes and artifacts which make it difficult to evaluate or detect malignant tissue. It is important to be aware of normal variants and benign diseases that may mimic more serious pathology. Uptake of FDG in a number of sites may be variable and may normally be seen in the skeletal muscle after exercise or under tension, in the myocardium, in parts of the gastrointestinal tract, especially the stomach and cecum, and in the urinary tract. Some causes of increased physiologic uptake are avoidable, and measures can be taken to minimize accumulation (Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of F-18 deoxyglucose PET scanning: Potential for error in interpretation. Semin Nucl Med. 1996;26:308–14).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of F-18 deoxyglucose PET scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308–14.
O’Tuama LA, Phillips PC, Smith IR, et al. l-methionine uptake by human cerebral cortex. Maturation from infancy to old age. J Nucl Med. 1991;32:16–20.
Newberg A, Alvi A, Reivich M. Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders. Semin Nucl Med. 2002;32:13–34.
Tashiro M, Fujimoto T, Itoh M, et al. F-18 FDG PET imaging of muscle activity in runners. J Nucl Med. 1999;40:70–6.
Shreve PD, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.
Loessner A, Alvi A, Lewandrowski KU, et al. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med. 1995;36:1141–9.
Hany TF, Gharehpapagh E, Kamel EM, et al. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med. 2002;29:1393–8.
Yasuda S, Fuji H, Takahashi W, et al. Elevated F-18 FDG uptake in the posas muscle. Clin Nucl Med. 1998;23:716–7.
Kim S-K, Chung J-K, Kim B-T, et al. Relationship between gastrointestinal F-18 FDG accumulation and gastrointestinal symptoms in whole-body PET. Clin Pos Imaging. 1999;2:273–80.
Sugawara Y, Fisher SJ, Zasadny KR, et al. Preclinical and clinical studies of bone marrow uptake of F-18 FDG with or without granulocyte colony stimulating factor during chemotherapy. J Clin Oncol. 1998;16:173–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lee, HY., Lee, MC., Kim, E.E. (2013). Normal and Variable Patterns in PET. In: Kim, E., Lee, MC., Inoue, T., Wong, WH. (eds) Clinical PET and PET/CT. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0802-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0802-5_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0801-8
Online ISBN: 978-1-4419-0802-5
eBook Packages: MedicineMedicine (R0)